SACRAMENTO, Calif., July 17, 2017 —The Global Precision Medicine Industry Awards leadership named international life sciences corporation Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio”), the 2017, “Most Promising Cancer Screening Company” award winner; in recognition of Anpac Bio’s proprietary, “Cancer Differentiation Analysis” (CDA) liquid biopsy cancer screening and diagnostic support services. Citing Anpac Bio’s, “excellence in diagnostics services”, the Global Precision Medicine Industry […]
Anpac Technology USA (Anpac Bio)
3 Spring House Innovation Park, Suite 150
Ambler, PA 19002
Email: [email protected]
Phone Number: +1 (267) 810-6776
Anpac Bio-Medical Science Co., Ltd.
Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.